MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.
MAESTRAL - A Prospective, Multinational, Multicenter, Randomized, Double Blind, Double Dummy, Controlled Study Comparing the Efficacy and Safety of Moxifloxacin to That of Amoxicillin Clavulanic Acid for the Treatment of Subjects With Acute Exacerbations of Chronic Bronchitis.
A study to assess the safety and efficacy of moxifloxacin compared to that of amoxicillin-clavulanic acid for the treatment of subjects with acute exacerbation of chronic bronchitis.
Inclusion Criteria:
Outpatients with chronic bronchitis
Male or female subjects, >=60 years old
Post bronchodilator forced expiratory volume in one second (FEV1) less than or equal to 60% predicted and FEV1 / forced vital capacity (FVC) less than 70% at enrollment
Documented history of 2 or more AECB episodes, within 12 months of study enrollment, requiring a course of systemic antibiotics and/or systemic corticosteroids
All symptoms/signs must be present and confirmed by the Investigator:
Current or past cigarette smoker with equal to or greater than 20 pack year smoking history
Subjects must be exacerbation free for at least 30 days prior to enrollment
Subjects must be willing and able to complete the questionnaires and subject booklet without assistance
Exclusion Criteria:
Bruxelles - Brussel, 1020, Belgium
Shengyang, Liaoning 110004, China
Cali, Cauca Department, Colombia
Pardubice - Trnova, 530 09, Czechia
Praha - Malesice, 108 00, Czechia
Praha - Troja, 182 00, Czechia
Mezourlo, Larissa 41110, Greece
Pregiato Di Cava Dei Tirreni, Salerno 84013, Italy
Talsu, 3201, Latvia
S. Martinho Do Bispo, 3041-856, Portugal
Binningen, Canton of Basel-City 4102, Switzerland